UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Schizophrenia research, 2005-07, Vol.76 (2), p.247-265

2005

Volltextzugriff (PDF)

Remission in Schizophrenia: Critical and Systematic Review

Harvard review of psychiatry, 2012-11, Vol.20 (6), p.281-297

2012

Volltextzugriff (PDF)

Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the ReLiAM study

BMC psychiatry, 2022-12, Vol.22 (1), p.773-773, Article 773

2022

Volltextzugriff (PDF)

Context and contact: a comparison of patient and family engagement with early intervention services for psychosis in India and Canada

Psychological medicine, 2022-06, Vol.52 (8), p.1538-1547

2022

Volltextzugriff (PDF)

Comparison of clinical outcomes following 2 years of treatment of first-episode psychosis in urban early intervention services in Canada and India

British journal of psychiatry, 2020-09, Vol.217 (3), p.514-520

2020

Volltextzugriff (PDF)

Exceptionally High Clozapine-Associated Eosinophilia

Journal of clinical psychopharmacology, 2021-03, Vol.41 (2), p.216-218

2021

Volltextzugriff (PDF)

Strategies for Achieving Better Cognitive Health in Individuals with Schizophrenia Spectrum: A Focus on the Canadian Landscape: Stratégies pour atteindre une meilleure santé cognitive chez les personnes souffrant du spectre de la schizophrénie : un regard sur le paysage canadien

Canadian journal of psychiatry, 2024-07, p.7067437241261928

2024

Volltextzugriff (PDF)

The Best Predictor of the Future—the Metaverse, Mental Health, and Lessons Learned From Current Technologies

JMIR mental health, 2022-10, Vol.9 (10), p.e40410-e40410

2022

Volltextzugriff (PDF)

A systematic meta-review of patient-level predictors of psychological therapy outcome in major depressive disorder

Journal of affective disorders, 2022-11, Vol.317, p.307-318

2022

Volltextzugriff (PDF)

A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic

Schizophrenia research, 2019-02, Vol.204, p.443-444

2019

Volltextzugriff (PDF)

An observational study of antipsychotic medication discontinuation in first-episode psychosis: clinical and functional outcomes

Social Psychiatry and Psychiatric Epidemiology, 2022-07, Vol.57 (7), p.1329-1340

2022

Volltextzugriff (PDF)

Trust of patients and families in mental healthcare providers and institutions: a cross-cultural study in Chennai, India, and Montreal, Canada

Social Psychiatry and Psychiatric Epidemiology, 2024-05, Vol.59 (5), p.813-825

2024

Volltextzugriff (PDF)

Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?

Journal of Psychopharmacology, 2012-09, Vol.26 (9), p.1167-1174

2012

Volltextzugriff (PDF)

Comparing three‐year extension of early intervention service to regular care following two years of early intervention service in first‐episode psychosis: a randomized single blind clinical trial

World psychiatry, 2017-10, Vol.16 (3), p.278-286

2017

Volltextzugriff (PDF)

Economic Evaluation of Extended Early Intervention Service vs Regular Care Following 2 Years of Early Intervention: Secondary Analysis of a Randomized Controlled Trial

Schizophrenia bulletin, 2021-03, Vol.47 (2), p.465-473

2021

Volltextzugriff (PDF)

Manualized group cognitive behavioral therapy for social anxiety in first-episode psychosis: a randomized controlled trial

Psychological medicine, 2023-06, Vol.53 (8), p.3335-3344

2023

Volltextzugriff (PDF)

Generic formulations of psychotropic medications and treatment response

Journal of psychiatry & neuroscience, 2017-03, Vol.42 (2), p.E3-E4

2017

Volltextzugriff (PDF)

Unfinished business: Functional outcomes in a randomized controlled trial of a three‐year extension of early intervention versus regular care following two years of early intervention for psychosis

Acta psychiatrica Scandinavica, 2022-01, Vol.145 (1), p.86-99

2022

Volltextzugriff (PDF)

Switching medication products during the treatment of psychiatric illness

International journal of psychiatry in clinical practice, 2019-01, Vol.23 (1), p.2-13

2019

Volltextzugriff (PDF)

Whose responsibility? Part 2 of 2: views of patients, families, and clinicians about responsibilities for addressing the needs of persons with mental health problems in Chennai, India and Montreal, Canada

International journal of mental health systems, 2022-01, Vol.16 (1), p.2-2, Article 2

2022

Volltextzugriff (PDF)

Patient- and family-reported experiences of their treating teams in early psychosis services in Chennai, India and Montreal, Canada

Asian journal of psychiatry, 2024-08, Vol.98, p.104118, Article 104118

2024

Volltextzugriff (PDF)

Suicidality Over the First 5 Years of Psychosis: Does Extending Early Intervention Have Benefits?

Canadian journal of psychiatry, 2021-05, Vol.66 (5), p.468-476

2021

Volltextzugriff (PDF)

Switching from Brand‐Name to Generic Psychotropic Medications: A Literature Review

CNS neuroscience & therapeutics, 2011-12, Vol.17 (6), p.750-760

2011

Volltextzugriff (PDF)

Whose responsibility? Part 1 of 2: A scale to assess how stakeholders apportion responsibilities for addressing the needs of persons with mental health problems

International journal of mental health systems, 2022-01, Vol.16 (1), p.1-1, Article 1

2022

Volltextzugriff (PDF)

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences

Schizophrenia research, 2004-04, Vol.67 (2), p.157-166

2004

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(81)
Science & Technology
(81)
Psychiatry
(69)
Humans
(61)
Adult
(32)
Male
(32)
Female
(29)
Schizophrenia
(29)
Psychosis
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Middle Aged
(20)
Antipsychotic Agents - Adverse Effects
(19)
Schizophrenia - Drug Therapy
(19)
Pharmacology & Pharmacy
(17)
Antipsychotic Agents - Therapeutic Use
(16)
Pharmacology. Drug Treatments
(14)
Early Intervention
(12)
Patients
(12)
Antipsychotics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Remission in Schizophrenia: Critical and Systematic Review

Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the ReLiAM study

Context and contact: a comparison of patient and family engagement with early intervention services for psychosis in India and Canada

Comparison of clinical outcomes following 2 years of treatment of first-episode psychosis in urban early intervention services in Canada and India

Exceptionally High Clozapine-Associated Eosinophilia

Strategies for Achieving Better Cognitive Health in Individuals with Schizophrenia Spectrum: A Focus on the Canadian Landscape: Stratégies pour atteindre une meilleure santé cognitive chez les personnes souffrant du spectre de la schizophrénie : un regard sur le paysage canadien

The Best Predictor of the Future—the Metaverse, Mental Health, and Lessons Learned From Current Technologies

A systematic meta-review of patient-level predictors of psychological therapy outcome in major depressive disorder

A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic

An observational study of antipsychotic medication discontinuation in first-episode psychosis: clinical and functional outcomes

Trust of patients and families in mental healthcare providers and institutions: a cross-cultural study in Chennai, India, and Montreal, Canada

Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?

Comparing three‐year extension of early intervention service to regular care following two years of early intervention service in first‐episode psychosis: a randomized single blind clinical trial

Economic Evaluation of Extended Early Intervention Service vs Regular Care Following 2 Years of Early Intervention: Secondary Analysis of a Randomized Controlled Trial

Manualized group cognitive behavioral therapy for social anxiety in first-episode psychosis: a randomized controlled trial

Generic formulations of psychotropic medications and treatment response

Unfinished business: Functional outcomes in a randomized controlled trial of a three‐year extension of early intervention versus regular care following two years of early intervention for psychosis

Switching medication products during the treatment of psychiatric illness

Whose responsibility? Part 2 of 2: views of patients, families, and clinicians about responsibilities for addressing the needs of persons with mental health problems in Chennai, India and Montreal, Canada

Patient- and family-reported experiences of their treating teams in early psychosis services in Chennai, India and Montreal, Canada

Suicidality Over the First 5 Years of Psychosis: Does Extending Early Intervention Have Benefits?

Switching from Brand‐Name to Generic Psychotropic Medications: A Literature Review

Whose responsibility? Part 1 of 2: A scale to assess how stakeholders apportion responsibilities for addressing the needs of persons with mental health problems

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences

Suchergebnisse filtern